3.3. Synergistic Effect of EZH2 Inhibitor SHR2554 and HDAC Inhibitor HBI8000 on Induction of Cell Death in DLBCL Cell Lines. The gene discussed is HDAC9; the disease is diffuse large B-cell lymphoma.